(ABMD) Abiomed plans to sell 5 million shares in secondary.
(ARXT) Adams Respiratory Therapeutics’ NDA submission for prescription cough suppressant accepted by FDA.
(ASTI) Ascent Solar Tech trading up 30% after Norsk Hydro bought 1.6 million shares in the company.
(BLTI) Biolase $0.04 EPS vs -$0.01 estimates.
(CLE) Claire’s delayed quarterly reports over accounting review with the SEC.
(CLHB) Clean Harbors $0.56 EPS vs $0.58e.
(CVTX) CV Therapeutics says JACC publishes long-term safety and tolerability data from Ranolazine open label experience program.
(CTV) CommScope raised guidance.
(EDU) New Oriental Education & Technology gains exclusive rights to distribute Thomson’s Online training course for English teachers.
(ESLT) Elbit $0.57 EPS vs $0.50e.
(GM) General Motors $0.32 EPS (excluding items) but will refund $1 Billion for sub-prime charges in GMAC after sale of the unit.
(GNTA) Genta announced 30 million share offering to raise close to $15 million in institutional placement.
(GSK) GlaxoSmithKline received Tykerb approval from FDA yesterday as expected.
(GYMB) Gymboree $0.75 EPS vs $0.73e.
(HRB) H&R Block is warning due to mortgage exposure.
(HPQ) Hewlett-Packard hosts its annual shareholder meeting today.
(JCG) J.Crew $0.33 EPS versus $0.28 estimates.
(JNPR) Juniper Networks CFO and another EVP left the company.
(LEH) Lehman $1.96 EPS vs $1.95 estimates; stock down 2%.
(LEND) Accredited Home Lenders trading up 14% after huge drop yesterday.
(MYL) Mylan Labs announces tentative FDA approval for divalproex sodium extended-release tablets.
(PBY) Pep Boys named Jefferey Rachor as President/CEO, recently from Sonic Automotive.
(POSH) BabyUniverse announces execution of definitive merger agreement with eToys Direct; POSH holders will hold 1/3 of the new company.
(SEAC) Seachange -$0.13 EPS vs -$0.04 estimates.
(STGS) Stage Stores $0.88 EPS vs $0.87 estimates; company raised guidance.
(SURW) Surewest Communications $0.06 EPS vs $0.12e.
(UBET) Youbet.com posts small loss but guides to in-line for 2007; announced $10M buyback plan.
(ULBI) Ultralife Batteries awarded contract worth approximately $7 mln by U.K. Ministry of Defence.
(WSSI) Webside Story widened losses from -$0.07 to -$0.09 based on added option expenses.
For the research summary this morning click here.
For Goldman Sachs’ research summary click here.
Jon C. Ogg
March 14, 2007
Jon Ogg can be reached at email@example.com; he does not own securities in the companies he covers.